Related Experiment Video
Updated: Aug 7, 2026

Screening Ion Channels in Cancer Cells
Published on: June 16, 2023
Potassium channels as tumour markers
Walter Stühmer1, Frauke Alves, Franziska Hartung
1Max-Planck Institute for Experimental Medicine, Göttingen, Germany. wstuehm@gwdg.de
Abstract:
An increasing number of ion channels are being found to be causally involved in diseases, giving rise to the new field of "channelopathies". Cancer is no exception, and several ion channels have been linked to tumour progression. Among them is the potassium channel EAG (Ether-a-go-go). Over 75% of tumours have been tested positive using a monoclonal antibody specific for EAG, while inhibition of this channel decreased the proliferation of EAG expressing cells. The inhibition of EAG is accomplished using RNA interference, functional anti-EAG1 antibodies, or (unspecific) EAG channel blockers. Fluorescently labelled recombinant Fab fragments recognizing EAG allow the distribution of EAG to be visualized in an in vivo mouse tumour model.
Insights
The potassium channel EAG (Ether-a-go-go) is implicated in cancer progression. Inhibiting EAG channels significantly reduces tumor cell proliferation, offering a potential therapeutic target for cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Channelopathies
Background:
- Ion channels play crucial roles in cellular functions and are increasingly linked to diseases, a field known as channelopathies.
- The potassium channel EAG (Ether-a-go-go) has emerged as a potential factor in tumor development and progression.
Purpose of the Study:
- To investigate the role of the EAG potassium channel in cancer.
- To explore methods for inhibiting EAG channel activity in tumor cells.
Main Methods:
- Utilized a monoclonal antibody specific for EAG to detect channel expression in tumors.
- Employed RNA interference, anti-EAG1 antibodies, and channel blockers to inhibit EAG function.
- Used fluorescently labeled recombinant Fab fragments for in vivo visualization of EAG distribution in a mouse tumor model.
Main Results:
- EAG channel expression was detected in over 75% of tested tumors.
- Inhibition of EAG channel activity led to a decrease in the proliferation of EAG-expressing tumor cells.
- Successful in vivo visualization of EAG distribution in a mouse tumor model was achieved.
Conclusions:
- The EAG potassium channel is frequently expressed in tumors and contributes to cancer cell proliferation.
- Targeting the EAG channel presents a promising therapeutic strategy for cancer treatment.
- Advanced imaging techniques allow for the in vivo study of EAG channel localization in tumors.
Related Concept Videos
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
Mechanically-gated Ion Channels
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...

